136 related articles for article (PubMed ID: 27566024)
21. Sentinel node biopsy (SNB) in malignant melanoma as same day procedure vs delayed procedure: clinical and economic outcome.
Rødgaard JC; Kramer S; Stolle LB
J Plast Surg Hand Surg; 2014 Aug; 48(4):265-9. PubMed ID: 24328901
[TBL] [Abstract][Full Text] [Related]
22. Sentinel Lymph Node Biopsy Provides Prognostic Value in Thick Head and Neck Melanoma.
Monroe MM; Pattisapu P; Myers JN; Kupferman ME
Otolaryngol Head Neck Surg; 2015 Sep; 153(3):372-8. PubMed ID: 26070510
[TBL] [Abstract][Full Text] [Related]
23. Head and neck cutaneous melanoma: a retrospective observational study on 146 patients.
Koskivuo IO; Kinnunen IA; Suominen EA; Talve LA; Vihinen PP; Grénman RA
Acta Oncol; 2009; 48(3):460-7. PubMed ID: 18843562
[TBL] [Abstract][Full Text] [Related]
24. Sentinel node biopsy for melanoma. Analysis of our experience (125 patients).
Soliveres Soliveres E; García Marín A; Díez Miralles M; Nofuentes Riera C; Candela Gomis A; Moragón Gordon M; Antón Leal MÁ; García García S
Cir Esp; 2014 Nov; 92(9):609-14. PubMed ID: 24365603
[TBL] [Abstract][Full Text] [Related]
25. Should all melanoma patients undergo sentinel lymph node biopsy?
Ra JH; McMasters KM; Spitz FR
Curr Opin Oncol; 2006 Mar; 18(2):185-8. PubMed ID: 16462189
[TBL] [Abstract][Full Text] [Related]
26. The long-term results and prognostic significance of cutaneous melanoma surgery using sentinel node biopsy with triple technique.
Rutkowski P; Szydłowski K; Nowecki ZI; Sałamacha M; Goryń T; Mitręga-Korab B; Pieńkowski A; Dziewirski W; Zdzienicki M
World J Surg Oncol; 2015 Oct; 13():299. PubMed ID: 26462471
[TBL] [Abstract][Full Text] [Related]
27. Sentinel lymph node biopsy and survival in elderly patients with cutaneous melanoma.
Koskivuo I; Hernberg M; Vihinen P; Virolainen S; Talve L; Seppänen M; Vahlberg T; Jahkola T
Br J Surg; 2011 Oct; 98(10):1400-7. PubMed ID: 21638276
[TBL] [Abstract][Full Text] [Related]
28. Thick melanoma: prognostic value of positive sentinel nodes.
Vermeeren L; van der Ent FW; Sastrowijoto PS; Hulsewé KW
World J Surg; 2009 Nov; 33(11):2464-8. PubMed ID: 19649757
[TBL] [Abstract][Full Text] [Related]
29. Predictors and Survival Impact of False-Negative Sentinel Nodes in Melanoma.
Lee DY; Huynh KT; Teng A; Lau BJ; Vitug S; Lee JH; Stern SL; Foshag LJ; Faries MB
Ann Surg Oncol; 2016 Mar; 23(3):1012-8. PubMed ID: 26586498
[TBL] [Abstract][Full Text] [Related]
30. [Prognosis after sentinel node biopsy in malignant melanoma].
Lock-Andersen J; Horn J; Sjøstrand H
Ugeskr Laeger; 2006 Jun; 168(25):2457-62. PubMed ID: 16824370
[TBL] [Abstract][Full Text] [Related]
31. The impact of lymphoscintigraphy technique on the outcome of sentinel node biopsy in 1,313 patients with cutaneous melanoma: an Italian Multicentric Study (SOLISM-IMI).
Rossi CR; De Salvo GL; Trifirò G; Mocellin S; Landi G; Macripò G; Carcoforo P; Ricotti G; Giudice G; Picciotto F; Donner D; Di Filippo F; Montesco MC; Casara D; Schiavon M; Foletto M; Baldini F; Testori A
J Nucl Med; 2006 Feb; 47(2):234-41. PubMed ID: 16455628
[TBL] [Abstract][Full Text] [Related]
32. Sentinel lymph node biopsy is indicated for patients with thick clinically lymph node-negative melanoma.
Yamamoto M; Fisher KJ; Wong JY; Koscso JM; Konstantinovic MA; Govsyeyev N; Messina JL; Sarnaik AA; Cruse CW; Gonzalez RJ; Sondak VK; Zager JS
Cancer; 2015 May; 121(10):1628-36. PubMed ID: 25677366
[TBL] [Abstract][Full Text] [Related]
33. Sentinel node biopsy for skin melanoma.
Kovacević P; Visnjić M; Vlajković M; Kovacević T; Visnjić A
Vojnosanit Pregl; 2009 Aug; 66(8):657-62. PubMed ID: 19780422
[TBL] [Abstract][Full Text] [Related]
34. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
[TBL] [Abstract][Full Text] [Related]
35. [Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: the role of elective lymph node dissection for clinical stage I].
Wenzel S; Sagowski C; Neuber K; Kehrl W; Metternich FU
Laryngorhinootologie; 2003 Jan; 82(1):19-24. PubMed ID: 12548460
[TBL] [Abstract][Full Text] [Related]
36. Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single unit experience.
Fairbairn NG; Orfaniotis G; Butterworth M
J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):1396-402. PubMed ID: 22552263
[TBL] [Abstract][Full Text] [Related]
37. Variations in management of stage I to stage III cutaneous melanoma: a population-based study of clinical practices in France.
Grange F; Vitry F; Granel-Brocard F; Lipsker D; Aubin F; Hédelin G; Dalac S; Truchetet F; Michel C; Batard ML; Baury B; Halna JM; Schmutz JL; Delvincourt C; Reuter G; Dalle S; Bernard P; Danzon A
Arch Dermatol; 2008 May; 144(5):629-36. PubMed ID: 18490589
[TBL] [Abstract][Full Text] [Related]
38. Sentinel lymph node biopsy and melanoma: 2010 update Part I.
Stebbins WG; Garibyan L; Sober AJ
J Am Acad Dermatol; 2010 May; 62(5):723-34; quiz 735-6. PubMed ID: 20398810
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of incomplete sentinel node biopsy procedures and sentinel node positivity rates as surgical quality-assurance parameters in melanoma patients.
Spillane AJ; Haydu LE; Lee NC; Uren RF; Stretch JR; Shannon KF; Quinn MJ; Saw RP; McCarthy WH; Thompson JF
Ann Surg Oncol; 2012 Nov; 19(12):3919-25. PubMed ID: 22644517
[TBL] [Abstract][Full Text] [Related]
40. Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?
Mays MP; Martin RC; Burton A; Ginter B; Edwards MJ; Reintgen DS; Ross MI; Urist MM; Stromberg AJ; McMasters KM; Scoggins CR
Cancer; 2010 Mar; 116(6):1535-44. PubMed ID: 20108306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
